“Survivability Rates Based on Molecular Subtype, Stage and Metastasis of 36 months cohort in Breast Cancer Patients”, NMSJ, vol. 7, no. 1, pp. 29–38, Apr. 2022, doi: 10.20956/nmsj.v7i1.20092.